e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Tuberculosis and non-TB mycobacterial infection I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Public health guidance on programmatic management of latent tuberculosis infection in the European Union/European Economic Area
S. Rosales-Klintz (Solna, Sweden), M. Van Der Werf (Solna, Sweden)
Source:
International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I
Session:
Tuberculosis and non-TB mycobacterial infection I
Session type:
Oral Presentation
Number:
3817
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Rosales-Klintz (Solna, Sweden), M. Van Der Werf (Solna, Sweden). Public health guidance on programmatic management of latent tuberculosis infection in the European Union/European Economic Area. 3817
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area
Source: Eur Respir J, 53 (1) 1802077; 10.1183/13993003.02077-2018
Year: 2019
The cost of tuberculosis in Denmark
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013
Knowledge and practices of hospital employees on tuberculosis
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes
Source: Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018
Year: 2018
Impact and management of TB childhood outbreaks in EU/EEA
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013
The European union standards for tuberculosis care: Do they need an update?
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014
Geographical variation in the respiratory health of Great Britain
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016
Active case finding of tuberculosis, Tomsk (Russia)
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Childhood tuberculosis outbreaks in EU/EEA: A systematic review
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
The World Health Organization standards for tuberculosis care and management
Source: Eur Respir J, 51 (3) 1800098; 10.1183/13993003.00098-2018
Year: 2018
The World Health Organization actions on digital health for tuberculosis: perspectives for respiratory medicine
Source: Virtual Congress 2021 – Digital health in respiratory medicine: opportunities for everyone
Year: 2021
Comparison of tuberculosis surveillance systems in low-incidence industrialised countries
Source: Eur Respir J 2008; 32: 1616-1624
Year: 2008
Notified or missed cases? An assessment of successful linkage for referred tuberculosis patients in South India
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
The future of health care. The perspective of the UK Health Policy Makers
Source: ERS Summit on priorities in respiratory medicine 2011
Year: 2011
Evaluation of the accuracy of tuberculosis surveillance system by comparison with medical record in Korea
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013
Awareness and knowledge of pediatricians in Cebu City of the national tuberculosis control program in the management of tuberculosis in children
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Cross-border management of tuberculosis cases through an updated ERS/WHO TB consilium
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Latent TB infection: Patient choices and completion of treatment
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016
The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosis
Source: Annual Congress 2011 - Multidrug-resistant tuberculosis
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept